Scholarlink

Background <p>Radiation-induced injuries (RIs) to the esophagus (ESO) and proximal bronchial tree (PBT) represent one of the most frequently observed symptomatic adverse events in locally advanced non-small cell lung cancer (LA-NSCLC). The establishment of validated normal tissue complication probability (NTCP) models and subsequent dose constraint recommendations are especially essential in carbon-ion radiotherapy (CIRT), owing to its unique physical and biological properties.</p> Purpose <p>To establish NTCP models and derive corresponding dose constraints for symptomatic or severe RIs in ESO and PBT in LA-NSCLC treated with local effect model (LEM)-I-based CIRT.</p> Methods <p>This retrospective study analyzed 184 LA-NSCLC patients treated with CIRT at a median prescription dose of 77 Gy (RBE) in 3.5 Gy (RBE) per fraction. Lyman-Kutcher-Burman (LKB) NTCP models were developed for acute esophagitis (ARI-ESO), late ESO reaction (LRI-ESO), and late PBT toxicity (LRI-PBT). Predictive performance was evaluated using the area under the receiver operating characteristic curve (AUC-ROC) by comparing single dosimetric parameters versus multivariate nomograms.</p> Results <p>For grade ≥ 2 (symptomatic) ARI-ESO and grade ≥ 2/≥3 (severe) LRI-PBT, low <i>n</i> values (0.053±0.097, 0.139 ± 0.085, 0.224 ± 0.135, respectively) indicated predominant dependence on high-dose regions. In contrast, higher <i>n</i> values (0.381/0.362) observed for grade ≥ 2/≥3 late ESO toxicities suggested the use of dual constraints incorporating both maximum dose (D<sub>max</sub>) and mean dose (D<sub>mean</sub>). The best equivalent uniform dose (EUD) thresholds (ROC‑derived) defined a low‑risk cohort with an actual incidence of ≤1.9% for each adverse event. The proposed D<sub>max</sub> thresholds of 78 Gy (RBE) for ESO and 80 Gy (RBE) for PBT are expected to limit toxicity risk below 5%. Multivariate nomograms integrating high-dose metrics and D<sub>mean</sub> achieved AUC-ROC values of 0.823–0.884.</p> Conclusions <p>The first NTCP models for symptomatic toxicities of ESO and PBT were established in LA-NSCLC patients receiving LEM-I-based CIRT at ~3.5 Gy (RBE) per fraction with sequential systemic therapy. The ROC‑derived optimal EUD thresholds for discriminating NTCP risk were obtained with substantial AUC-ROC values. We also proposed NTCP-derived Dmax constraints and developed multivariate nomograms to facilitate routine clinical use. Further prospective studies in larger cohorts with extended follow-up were warranted.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Normal tissue complication probability modelling and predicting for carbon-ion radiotherapy-induced symptomatic esophageal and tracheobronchial injuries in locally advanced non-small cell lung cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月18日

查看全文
  • Xue Ming,
  • Ningyi Ma,
  • Yinxiangzi Sheng,
  • Jian Chen,
  • Kailiang Wu,
  • Jingfang Mao

摘要

Background

Radiation-induced injuries (RIs) to the esophagus (ESO) and proximal bronchial tree (PBT) represent one of the most frequently observed symptomatic adverse events in locally advanced non-small cell lung cancer (LA-NSCLC). The establishment of validated normal tissue complication probability (NTCP) models and subsequent dose constraint recommendations are especially essential in carbon-ion radiotherapy (CIRT), owing to its unique physical and biological properties.

Purpose

To establish NTCP models and derive corresponding dose constraints for symptomatic or severe RIs in ESO and PBT in LA-NSCLC treated with local effect model (LEM)-I-based CIRT.

Methods

This retrospective study analyzed 184 LA-NSCLC patients treated with CIRT at a median prescription dose of 77 Gy (RBE) in 3.5 Gy (RBE) per fraction. Lyman-Kutcher-Burman (LKB) NTCP models were developed for acute esophagitis (ARI-ESO), late ESO reaction (LRI-ESO), and late PBT toxicity (LRI-PBT). Predictive performance was evaluated using the area under the receiver operating characteristic curve (AUC-ROC) by comparing single dosimetric parameters versus multivariate nomograms.

Results

For grade ≥ 2 (symptomatic) ARI-ESO and grade ≥ 2/≥3 (severe) LRI-PBT, low n values (0.053±0.097, 0.139 ± 0.085, 0.224 ± 0.135, respectively) indicated predominant dependence on high-dose regions. In contrast, higher n values (0.381/0.362) observed for grade ≥ 2/≥3 late ESO toxicities suggested the use of dual constraints incorporating both maximum dose (Dmax) and mean dose (Dmean). The best equivalent uniform dose (EUD) thresholds (ROC‑derived) defined a low‑risk cohort with an actual incidence of ≤1.9% for each adverse event. The proposed Dmax thresholds of 78 Gy (RBE) for ESO and 80 Gy (RBE) for PBT are expected to limit toxicity risk below 5%. Multivariate nomograms integrating high-dose metrics and Dmean achieved AUC-ROC values of 0.823–0.884.

Conclusions

The first NTCP models for symptomatic toxicities of ESO and PBT were established in LA-NSCLC patients receiving LEM-I-based CIRT at ~3.5 Gy (RBE) per fraction with sequential systemic therapy. The ROC‑derived optimal EUD thresholds for discriminating NTCP risk were obtained with substantial AUC-ROC values. We also proposed NTCP-derived Dmax constraints and developed multivariate nomograms to facilitate routine clinical use. Further prospective studies in larger cohorts with extended follow-up were warranted.